Literature DB >> 3800887

Oxidation of reduced Cu,Zn superoxide dismutase by molecular oxygen. A kinetic study.

P Viglino, M Scarpa, F Coin, G Rotilio, A Rigo.   

Abstract

The rate of oxidation of reduced bovine Cu,Zn superoxide dismutase [ECu(I)] by molecular O2 was studied by magnetic-resonance techniques and was found to be low under physiological conditions. The analysis of the kinetic data and of the experiments carried out in the presence of tetranitromethane confirms that O2.- is a product of the oxidation process. At [ECu(I)]/([ECu(I)] + [ECu(II)]) greater than 0.5 the O2.- produced reacts mainly with ECu(I), increasing the oxidation rate of the enzyme, whereas at [ECu(I)]/([ECu(I)] + [ECu(II)]) less than 0.5 it reacts mainly with ECu(II), decreasing the oxidation rate, the kinetics, at constant O2 concentration, being an apparent second-order process. The oxidation rate increased linearly with both O2 and OH- concentration, indicating that only a deprotonated form of the ECu(I) reacts with O2.-.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3800887      PMCID: PMC1146984          DOI: 10.1042/bj2370305

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  15 in total

1.  Polarographic determination of superoxide dismutase.

Authors:  A Rigo; P Viglino; G Rotilio
Journal:  Anal Biochem       Date:  1975-09       Impact factor: 3.365

2.  Preparation of reduced bovine Cu,Zn superoxide dismutase.

Authors:  P Viglino; M Scarpa; D Cocco; A Rigo
Journal:  Biochem J       Date:  1985-07-01       Impact factor: 3.857

3.  Observations on the oxidation-reduction properties of bovine erythrocyte superoxide dismutase.

Authors:  J A Fee; P E DiCorleto
Journal:  Biochemistry       Date:  1973-11-20       Impact factor: 3.162

4.  Reversal of the superoxide dismutase reaction.

Authors:  E K Hodgson; I Fridovich
Journal:  Biochem Biophys Res Commun       Date:  1973-09-05       Impact factor: 3.575

5.  Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein).

Authors:  J M McCord; I Fridovich
Journal:  J Biol Chem       Date:  1969-11-25       Impact factor: 5.157

6.  Electrostatic recognition between superoxide and copper, zinc superoxide dismutase.

Authors:  E D Getzoff; J A Tainer; P K Weiner; P A Kollman; J S Richardson; D C Richardson
Journal:  Nature       Date:  1983 Nov 17-23       Impact factor: 49.962

7.  Phosphate is an inhibitor of copper-zinc superoxide dismutase.

Authors:  D Mota de Freitas; J S Valentine
Journal:  Biochemistry       Date:  1984-04-24       Impact factor: 3.162

8.  Reduction and inactivation of superoxide dismutase by hydrogen peroxide.

Authors:  R C Bray; S A Cockle; E M Fielden; P B Roberts; G Rotilio; L Calabrese
Journal:  Biochem J       Date:  1974-04       Impact factor: 3.857

9.  Mechanism of action of superoxide dismutase from pulse radiolysis and electron paramagnetic resonance. Evidence that only half the active sites function in catalysis.

Authors:  E M Fielden; P B Roberts; R C Bray; D J Lowe; G N Mautner; G Rotilio; L Calabrese
Journal:  Biochem J       Date:  1974-04       Impact factor: 3.857

10.  Crystal structure of bovine Cu,Zn superoxide dismutase at 3 A resolution: chain tracing and metal ligands.

Authors:  J Richardson; K A Thomas; B H Rubin; D C Richardson
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

View more
  3 in total

Review 1.  A role for copper in the toxicity of zinc-deficient superoxide dismutase to motor neurons in amyotrophic lateral sclerosis.

Authors:  Kari A Trumbull; Joseph S Beckman
Journal:  Antioxid Redox Signal       Date:  2009-07       Impact factor: 8.401

2.  Reactivity of an active center analog of Cu2Zn2superoxide dismutase in murine model of acute and chronic inflammation.

Authors:  R Miesel; R Haas
Journal:  Inflammation       Date:  1993-10       Impact factor: 4.092

3.  Loss of oxidation-reduction specificity in amyotrophic lateral sclerosis-associated CuZnSOD mutants.

Authors:  C Cafe; M P Testa; P J Sheldon; W P French; L M Ellerby; D E Bredesen
Journal:  J Mol Neurosci       Date:  2000-10       Impact factor: 2.866

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.